Tchkonia, T
Ozempic: FDA Approval and Advancements in Diabetes Treatment Since its initial approval by the Food and Drug Administration (FDA) in 2017, Ozempic has revolutionized diabetes treatment, earning multiple FDA approvals for a wide range of conditions and doses
However, excessive pregnancy weight gain (defined as more than recommended ranges by pre-pregnancy BMI) increases risks for gestational diabetes, preeclampsia, and postpartum weight retention
SEMA: once-weekly subcutaneous semaglutide 2.4 mg
Raverdy V, Tavaglione F, Chatelain E, Caiazzo R, Saponaro C, Lassailly G, et al
Experimental studies have explored its effects in models involving soft tissue injury, gastrointestinal function, vascular biology, and musculoskeletal recovery